Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages

Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

(2013) S. Rusakiewicz et al.   CANCER RESEARCH

Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1

(2012) A. Glasner et al.   JOURNAL OF IMMUNOLOGY

NK cells sense tumors, course of disease and treatments

(2012) Giulia Fregni et al.   OncoImmunology

Matrix Metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12- and OX40L-Dependent Pathway

(2011) Emmanuelle Godefroy et al.   CANCER CELL

Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition

(2011) E. Mamessier et al.   CANCER RESEARCH

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

(2011) S. Platonova et al.   CANCER RESEARCH

Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy

(2011) G. Fregni et al.   CLINICAL CANCER RESEARCH

Association between natural killer cells and regression in melanocytic lesions

(2011) Kristopher McKay et al.   HUMAN PATHOLOGY

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection

(2011) Joseph C. Sun et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells

(2011) Jeffrey L. Wong et al.   JOURNAL OF IMMUNOTHERAPY

Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

(2011) A Perier et al.   ONCOGENE

Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer

(2011) Mathilde Allard et al.   PLoS One

Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction

(2010) G. Konjević et al.   BIOMEDICINE & PHARMACOTHERAPY

Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment

(2010) Nathalie T. Joncker et al.   JOURNAL OF EXPERIMENTAL MEDICINE

MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment

(2010) Julie M. Elliott et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients

(2010) Katarina Mirjačić Martinović et al.   JOURNAL OF SURGICAL RESEARCH

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients

(2009) G Pittari et al.   BONE MARROW TRANSPLANTATION

Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1

(2009) G. G. Halfteck et al.   JOURNAL OF IMMUNOLOGY

Human natural killer cells

(2008) M. A. Caligiuri   BLOOD

Expression of Ligands to NKp46 in Benign and Malignant Melanocytes

(2007) Emanuela Cagnano et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY